Font Size: a A A
Keyword [SGLT-2]
Result: 1 - 20 | Page: 1 of 2
1. Studies On The Chemical Constituents And Bioactivities Of Gordonia Chrysandra And Gordonia Kwangsiensis
2. Sglt - 2 Diabetes Drug Design And Synthesis Of Inhibitors
3. Sglt - 2 Inhibitor Ertugliflozin Synthesis
4. Effects Of SGLT-2 Inhibitors On Macrovascular Risk Factors In Type 2 Diabetes:a Systematic Review
5. Research And Development Of Synthetic Process Of SGLT-2 Inhibitor
6. Empagliflozin And Other Antidiabetic Agents For Type 2 Diabetes: A Systematic Review
7. The Study Of The Synthesis Of The Drugs Against Type ? Diabetes—Ipragliflozin And The Key Intermediate Of Tofogliflozin
8. The Interventional Study Of Empagliflozin,a SGLT-2 Inhibitor,on Ventricular Remodeling And Mitochondrial Function In Type 2 Diabetic Rats
9. Effects Of SGLT-2 Inhibitors Combined With Insulin In Diabetes On Risk Factors Of Cardiovascular Disease: A Meta-analysis Of Randomized Controlled Trials
10. Efficacy And Safety Of Triple Therapy With Sodium Glucose Co-transporter 2(SGLT-2)Inhibitor Add-on To Dipeptidyl Peptidase-4(DPP-4)Inhibitor Plus Metformin For Type 2 Diabetes:A Systematic Review
11. Systematic Evaluation And Meta-analysis Of SGLT-2 Inhibitors Combined With Insulin In The Treatment Of Type 1 Diabetes
12. Effects Of Sodium Glucose Cotransporter-2 Inhibitors On Lipids In Patients With Type 2 Diabetes:a Systematic Review
13. The Effects Of Novelantidiabetic Drugs On Albuminuria In Type 2 Diabetes Mellitus
14. Short-term Clinical Efficacy And Safety Of Dapagliflozin In The Treatment Of Type 2 Diabetes
15. Effects Of Sodium Glucose Cotransporter-2 Inhibitors On Body Weight And Blood Pressure In Patients Of Type 2 Diabetes
16. A Systematic Review And Meta-anaylsis On The Effects Of SGLT-2 Inhibitors On Insulin Resistance In Overweight And Obese Type 2diabetic Patients
17. Meta Analysis Of The Effect Of SGLT2 Inhibitor On Oxidative Stress In Overweight Or Obese Type 2 Diabetic Patients
18. The Effects Of SGLT-2 Inhibitors On Kidney Function In Patients With Type 2 Diabetes:A Meta-analysis
19. Meta-analysis Of Efficacy And Safety Of SGLT-2 Inhibitors In The Treatment Of Patients With Type 2 Diabetes With Chronic Kidney Disease
20. Synthesis And Pharmacodynamics Study Of A Dual SGLT-1/SGLT-2 Inhibitor
  <<First  <Prev  Next>  Last>>  Jump to